Congenital Heart anomalies or Congenital heart disease (CHD) is the most common congenital disorder in newborns. This article focuses on the use of pulse oximetry for the screening of CHD in newborns. Congenital heart disease (CHD) is the most common congenital disorder in newborns. Critical CHD, defined as requiring surgery or catheter-based intervention in the first year of life, occurs in approximately 25 percent of those with CHD.
Although many newborns with critical CHD are symptomatic and identified soon after birth, others are not diagnosed until after discharge from the birth hospitalization. In infants with critical cardiac lesions, the risk of morbidity and mortality increases when there is a delay in diagnosis and timely referral to a tertiary center with expertise in treating these patients. Recommendations for Pulse Oximetry Screening The goal of critical CHD screening in…
